{"title":"Evolution of chorioretinal lesions in acute posterior multifocal placoid pigment epitheliopathy with OCT and OCT-angiography.","authors":"A Zahaf, S Selmi, H Lajmi, S Sioud, B Ben Achour","doi":"10.1016/j.jfo.2025.104558","DOIUrl":"https://doi.org/10.1016/j.jfo.2025.104558","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144132141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ophthalmic artery occlusion following a branch retinal artery occlusion in a patient with carotid stenosis.","authors":"D Zhu, K Patel, M Bouaziz, R Lieberman","doi":"10.1016/j.jfo.2025.104557","DOIUrl":"https://doi.org/10.1016/j.jfo.2025.104557","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144132321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Tomographie par cohérence optique-angiographie (Optical coherence tomography angiography (OCTA) et nerf optique (hors glaucome)","authors":"H. Merle , M. Pierre , A. Jean-Charles","doi":"10.1016/j.jfo.2025.104546","DOIUrl":"10.1016/j.jfo.2025.104546","url":null,"abstract":"<div><div>La tomographie par cohérence optique-angiographie (<em>optical coherence tomography angiography</em> ([OCTA]) est un examen non invasif, fiable et reproductible. Contrairement à l’angiographie à la fluorescéine, l’OCTA permet d’analyser le lit capillaire sans être gêné par les phénomènes de diffusion. Son emploi est maintenant largement répandu pour le diagnostic et le suivi des maladies rétiniennes et choroïdiennes. Cependant, son usage dans l’exploration du nerf optique est encore limité. Récemment, l’arrivée de logiciels qui permettent une quantification des données, complètent les images de la vascularisation maculaire et papillaire. Cette revue expose les résultats obtenus en OCTA au cours de l’exploration des principales affections du nerf optique acquises ou congénitales en dehors de la neuropathie optique glaucomateuse. Dans la plupart des cas, l’OCTA montrent des modifications de la vascularisation rétinienne ou papillaire en corrélation avec l’atteinte des fibres nerveuses rétiniennes, de la couche des cellules ganglionnaires et la fonction visuelle. L’OCTA contribue à améliorer la compréhension physiopathologique des affections du nerf optique sans pouvoir encore préciser si ces modifications sont une cause ou une conséquence de la maladie. L’utilisation de l’OCTA est pertinente en neuro-ophtalmologie. Outre la détection et le diagnostic, l’OCTA pourrait être employé pour le suivi ou la surveillance des traitements mis en place.</div></div><div><div>Optical coherence tomography angiography (OCTA) is a non-invasive, reliable, repeatable exam. As opposed to fluorescein angiography, OCTA allows analysis of the capillary bed without interference from diffusion phenomena. It is now widely used for both the diagnosis and ongoing care of retinal and choroidal diseases. However, its use is still limited for evaluation of the optic nerve. Recently, new data quantification software can add value to macular and papillary vascularization images. This review details OCTA results in the most important optic nerve conditions, whether acquired or congenital, other than glaucoma. In most cases, OCTA shows modifications of the retinal or papillary vascularization systematically impacting retinal nerve fibers, ganglion cells layer and visual acuity. OCTA contributes to a better understanding of the pathophysiology of optic nerve disease without being able to specify yet whether the modifications cause or are caused by the disease. OCTA is particularly useful for neuro-ophthalmology. In addition to detection and diagnosis, OCTA can be used for follow-up and monitoring of treatment response.</div></div>","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 6","pages":"Article 104546"},"PeriodicalIF":1.2,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144090167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Schwartz-Matsuo syndrome with lens coloboma.","authors":"S Chaudhary, N Babu, A D Sarkar","doi":"10.1016/j.jfo.2025.104555","DOIUrl":"https://doi.org/10.1016/j.jfo.2025.104555","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144119773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I Daoudi, A Mabchour, F Rasquin, L Van Bol, P Demols
{"title":"Retinal arterial macroaneurysm rupture in a 17-year-old: Could cannabis consumption be a risk factor?","authors":"I Daoudi, A Mabchour, F Rasquin, L Van Bol, P Demols","doi":"10.1016/j.jfo.2025.104559","DOIUrl":"https://doi.org/10.1016/j.jfo.2025.104559","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144110747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Retinal vascular occlusion as presenting sign of occult gynecological cancer.","authors":"F Navarro, X Boulu, Y Guellab, T H C Tran","doi":"10.1016/j.jfo.2025.104556","DOIUrl":"https://doi.org/10.1016/j.jfo.2025.104556","url":null,"abstract":"","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":" ","pages":""},"PeriodicalIF":1.2,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144110748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
L. Béal , M. Lamiaux , E. Guerrien-Sevrin , A. Lasek , P. Modiano , S. Doan , T.H.C. Tran
{"title":"Ocular surface evaluation in atopic dermatitis patients on dupilumab: A prospective observational study","authors":"L. Béal , M. Lamiaux , E. Guerrien-Sevrin , A. Lasek , P. Modiano , S. Doan , T.H.C. Tran","doi":"10.1016/j.jfo.2025.104544","DOIUrl":"10.1016/j.jfo.2025.104544","url":null,"abstract":"<div><h3>Purpose</h3><div>To describe the ocular surface findings in atopic dermatitis patients treated with dupilumab.</div></div><div><h3>Method</h3><div>This is an observational study including atopic dermatitis patients treated with dupilumab from January 2018 to July 2019. At baseline, patients underwent dermatological and ophthalmological assessments and at least one other joint visit during the 6-month follow-up. Appointments were scheduled at baseline, 1, 3, and 6<!--> <!-->months for ophthalmologists. Ocular assessment included past ocular history and symptoms, Ocular Surface Disease Index (OSDI) score, slit lamp examination, tear film Break Up Time and Schirmer's test. Atopic dermatitis severity scores were assessed at baseline and 3 and 6<!--> <!-->months by dermatologists.</div></div><div><h3>Results</h3><div>Forty-six patients were included. Among them, 31 (67%) had preexisting ocular surface disease at baseline. Mean follow-up was 7.1<!--> <!-->±<!--> <!-->1.6<!--> <!-->months. At the 6-month endpoint, 8 patients (17%) developed newly diagnosed ocular surface disease; 13 patients (28%) experienced exacerbation of ocular surface disease; 8 patients (17%) had stable ocular surface disease, 10 patients (22%) experienced an improvement in their ocular surface disease on dupilumab, and 7 patients (15%) had no ocular surface disease from baseline to the endpoint. The presence of eyelid eczema at baseline was associated with the occurrence of dupilumab induced ocular surface disease. Only 3 patients (7%) had to discontinue treatment due to ocular adverse events.</div></div><div><h3>Conclusion</h3><div>Atopic dermatitis patients treated with dupilumab may develop polymorphic, potentially severe ocular surface disease. These results highlight the need for careful examination of the eyelids and globe of atopic dermatitis patients and early examination by ophthalmologists if conjunctivitis does not resolve with non-steroid eye drops.</div></div><div><h3>Objectif</h3><div>Décrire les atteintes de surface oculaire au cours des dermatites atopiques sous dupilumab.</div></div><div><h3>Méthode</h3><div>Il s’agit d’une étude observationnelle réalisée entre janvier 2018 et juillet 2019, chez des patients ayant une dermatite atopique et pour qui du dupilumab a été introduit. Le suivi ophtalmologique a été réalisé à l’inclusion, au 1<sup>er</sup>, 3<sup>e</sup> et 6<sup>e</sup> mois. L’ophtalmologue évaluait les antécédents et les symptômes oculaires, le score OSDI (Ocular Surface Disease Index), le segment antérieur en biomicroscopie, le BUT et réalisait un test de Schirmer. L’examen dermatologique déterminait le score de sévérité de la dermatite atopique à l’inclusion, au 3<sup>e</sup> et au 6<sup>e</sup> mois.</div></div><div><h3>Résultats</h3><div>Quarante-six patients ont été inclus. Trente et un (67 %) avaient dès l’inclusion une atteinte pré-existante de surface oculaire. Le suivi moyen était de 7,1<!--> <!-->±<!--> <!-->1,6 mois. À 6 mois, 8 pa","PeriodicalId":14777,"journal":{"name":"Journal Francais D Ophtalmologie","volume":"48 6","pages":"Article 104544"},"PeriodicalIF":1.2,"publicationDate":"2025-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143916952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}